glp-1 asa medications safe to continue before surgery in patients with diabetes and obesity The 2023 ASA position on
Description
In 2023, national data showed adult obesity plateauing for the first time in more than a decade
Most GLP-1 agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) do not require dose adjustment for mild-to-moderate renal impairment, though caution is warranted in severe renal impairment
Is Semaglutide GLP-1 better than Liraglutide
We also integrate nutrition guidance, behavior coaching, and meal-planning support to ensure you get the most out of your treatment
SHED Commission: $350 CPA
Combination therapy with liraglutide yielded greater HbA1c and weight reductions compared to dulaglutide
